vs
MARCUS CORP（MCS）与MADRIGAL PHARMACEUTICALS, INC.（MDGL）财务数据对比。点击上方公司名可切换其他公司
MADRIGAL PHARMACEUTICALS, INC.的季度营收约是MARCUS CORP的1.7倍（$321.1M vs $193.5M），MADRIGAL PHARMACEUTICALS, INC.同比增速更快（210.8% vs 2.8%），MARCUS CORP自由现金流更多（$26.4M vs $-133.8M）
马库斯公司是一家美国企业，主营商业地产领域相关服务，业务覆盖美国与加拿大，提供商业地产经纪、按揭经纪、行业研究以及咨询服务，首创了由单一经纪公司独家代理房源挂牌的行业模式，目前在美加两国设有超过80家办公室，拥有员工超1800名。
本公司是一家美国生物制药企业，成立于2002年，专注于研发新型合成胆汁酸类似物，可用于治疗原发性胆汁性胆管炎、非酒精性脂肪肝、肝硬化等慢性肝病，以及胆汁酸性腹泻等肠道疾病。
MCS vs MDGL — 直观对比
营收规模更大
MDGL
是对方的1.7倍
$193.5M
营收增速更快
MDGL
高出208.0%
2.8%
自由现金流更多
MCS
多$160.2M
$-133.8M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $193.5M | $321.1M |
| 净利润 | — | $-58.6M |
| 毛利率 | — | — |
| 营业利润率 | 0.9% | -18.6% |
| 净利率 | — | -18.2% |
| 营收同比 | 2.8% | 210.8% |
| 净利润同比 | — | 1.4% |
| 每股收益（稀释后） | — | $-2.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MCSMDGL
| Q4 25 | $193.5M | $321.1M | ||
| Q3 25 | $210.2M | $287.3M | ||
| Q2 25 | $206.0M | $212.8M | ||
| Q1 25 | $148.8M | $137.3M | ||
| Q4 24 | $188.3M | $103.3M | ||
| Q3 24 | $232.7M | $62.2M | ||
| Q2 24 | $176.0M | — | ||
| Q1 24 | $138.5M | $0 |
净利润MCSMDGL
| Q4 25 | — | $-58.6M | ||
| Q3 25 | $16.2M | $-114.2M | ||
| Q2 25 | $7.3M | $-42.3M | ||
| Q1 25 | $-16.8M | $-73.2M | ||
| Q4 24 | $986.0K | $-59.4M | ||
| Q3 24 | $23.3M | $-107.0M | ||
| Q2 24 | $-20.2M | — | ||
| Q1 24 | $-11.9M | $-147.5M |
毛利率MCSMDGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 96.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率MCSMDGL
| Q4 25 | 0.9% | -18.6% | ||
| Q3 25 | 10.8% | -39.7% | ||
| Q2 25 | 6.3% | -22.2% | ||
| Q1 25 | -13.7% | -57.8% | ||
| Q4 24 | -1.2% | -64.8% | ||
| Q3 24 | 14.1% | -187.1% | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | -12.0% | — |
净利率MCSMDGL
| Q4 25 | — | -18.2% | ||
| Q3 25 | 7.7% | -39.8% | ||
| Q2 25 | 3.6% | -19.9% | ||
| Q1 25 | -11.3% | -53.4% | ||
| Q4 24 | 0.5% | -57.5% | ||
| Q3 24 | 10.0% | -172.0% | ||
| Q2 24 | -11.5% | — | ||
| Q1 24 | -8.6% | — |
每股收益（稀释后）MCSMDGL
| Q4 25 | — | $-2.55 | ||
| Q3 25 | — | $-5.08 | ||
| Q2 25 | — | $-1.90 | ||
| Q1 25 | — | $-3.32 | ||
| Q4 24 | — | $-2.50 | ||
| Q3 24 | — | $-4.92 | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-7.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $23.4M | $198.7M |
| 总债务越低越好 | $159.0M | $339.9M |
| 股东权益账面价值 | $457.4M | $602.7M |
| 总资产 | $1.0B | $1.3B |
| 负债/权益比越低杠杆越低 | 0.35× | 0.56× |
8季度趋势，按日历期对齐
现金及短期投资MCSMDGL
| Q4 25 | $23.4M | $198.7M | ||
| Q3 25 | $7.4M | $295.7M | ||
| Q2 25 | $14.9M | $186.2M | ||
| Q1 25 | $11.9M | $183.6M | ||
| Q4 24 | $40.8M | $100.0M | ||
| Q3 24 | $28.4M | $232.7M | ||
| Q2 24 | $32.8M | — | ||
| Q1 24 | $17.3M | $622.5M |
总债务MCSMDGL
| Q4 25 | $159.0M | $339.9M | ||
| Q3 25 | $162.0M | $339.8M | ||
| Q2 25 | $179.9M | $118.4M | ||
| Q1 25 | $198.9M | $118.0M | ||
| Q4 24 | $159.1M | $117.6M | ||
| Q3 24 | $173.1M | $117.1M | ||
| Q2 24 | $175.7M | — | ||
| Q1 24 | $169.8M | $116.1M |
股东权益MCSMDGL
| Q4 25 | $457.4M | $602.7M | ||
| Q3 25 | $454.3M | $625.7M | ||
| Q2 25 | $448.4M | $696.0M | ||
| Q1 25 | $441.8M | $710.6M | ||
| Q4 24 | $464.9M | $754.4M | ||
| Q3 24 | $462.3M | $777.2M | ||
| Q2 24 | $449.4M | — | ||
| Q1 24 | $459.3M | $850.8M |
总资产MCSMDGL
| Q4 25 | $1.0B | $1.3B | ||
| Q3 25 | $1.0B | $1.4B | ||
| Q2 25 | $1.0B | $1.0B | ||
| Q1 25 | $1.0B | $996.6M | ||
| Q4 24 | $1.0B | $1.0B | ||
| Q3 24 | $1.0B | $1.1B | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $1.0B | $1.1B |
负债/权益比MCSMDGL
| Q4 25 | 0.35× | 0.56× | ||
| Q3 25 | 0.36× | 0.54× | ||
| Q2 25 | 0.40× | 0.17× | ||
| Q1 25 | 0.45× | 0.17× | ||
| Q4 24 | 0.34× | 0.16× | ||
| Q3 24 | 0.37× | 0.15× | ||
| Q2 24 | 0.39× | — | ||
| Q1 24 | 0.37× | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $48.8M | $-133.5M |
| 自由现金流经营现金流 - 资本支出 | $26.4M | $-133.8M |
| 自由现金流率自由现金流/营收 | 13.6% | -41.7% |
| 资本支出强度资本支出/营收 | 11.6% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $989.0K | — |
8季度趋势，按日历期对齐
经营现金流MCSMDGL
| Q4 25 | $48.8M | $-133.5M | ||
| Q3 25 | $39.1M | $79.8M | ||
| Q2 25 | $31.6M | $-47.1M | ||
| Q1 25 | $-35.3M | $-88.9M | ||
| Q4 24 | $52.6M | $-104.5M | ||
| Q3 24 | $30.5M | $-67.0M | ||
| Q2 24 | $36.0M | — | ||
| Q1 24 | $-15.1M | $-149.2M |
自由现金流MCSMDGL
| Q4 25 | $26.4M | $-133.8M | ||
| Q3 25 | $18.2M | $79.0M | ||
| Q2 25 | $14.7M | — | ||
| Q1 25 | $-58.3M | — | ||
| Q4 24 | $27.1M | $-104.7M | ||
| Q3 24 | $12.0M | $-67.8M | ||
| Q2 24 | $16.1M | — | ||
| Q1 24 | $-30.5M | $-149.5M |
自由现金流率MCSMDGL
| Q4 25 | 13.6% | -41.7% | ||
| Q3 25 | 8.7% | 27.5% | ||
| Q2 25 | 7.1% | — | ||
| Q1 25 | -39.2% | — | ||
| Q4 24 | 14.4% | -101.3% | ||
| Q3 24 | 5.2% | -109.0% | ||
| Q2 24 | 9.2% | — | ||
| Q1 24 | -22.0% | — |
资本支出强度MCSMDGL
| Q4 25 | 11.6% | 0.1% | ||
| Q3 25 | 9.9% | 0.3% | ||
| Q2 25 | 8.2% | 0.0% | ||
| Q1 25 | 15.5% | 0.0% | ||
| Q4 24 | 13.5% | 0.2% | ||
| Q3 24 | 7.9% | 1.3% | ||
| Q2 24 | 11.3% | — | ||
| Q1 24 | 11.1% | — |
现金转化率MCSMDGL
| Q4 25 | — | — | ||
| Q3 25 | 2.41× | — | ||
| Q2 25 | 4.32× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 53.31× | — | ||
| Q3 24 | 1.31× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MCS
| Theatres | $123.1M | 64% |
| Concessions | $51.0M | 26% |
| Food And Beverage | $21.2M | 11% |
MDGL
| Rebates Customer Fees Credits Co Pay Assistance And Other | $208.5M | 65% |
| Other | $76.0M | 24% |
| Chargebacks Discounts For Prompt Pay And Other Allowances | $36.6M | 11% |
